HIV Infection: WHO disease staging system
WHO Disease Staging System for HIV Infection and Disease was first produced in 1990 by the World Health Organisation [1] and updated in September 2005. It is an approach for use in resource limited settings and is widely used in Africa and Asia and has been a useful research tool in studies of progression to symptomatic HIV disease. Most of these conditions are opportunistic infections that can be easily treated in healthy people. The staging system is different for adults and adolescents and children.
Stage I: HIV disease is asymptomatic and not categorized as AIDS.
Stage II: include minor mucocutaneous manifestations and recurrent upper respiratory tract infections.
Stage III: includes unexplained chronic diarrhea for longer than a month, severe bacterial infections and pulmonary tuberculosis.
Stage IV: includes toxoplasmosis of the brain, candidiasis of the esophagus, trachea, bronchi or lungs and Kaposi's sarcoma; these diseases are used as indicators of AIDS.
See also
- WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents
- WHO Disease Staging System for HIV Infection and Disease in Children
Notes
- ↑ WHO (1990). "Interim proposal for a WHO Staging System for HIV infection and Disease" (PDF). Wkly Epidemiol Rec. 65 (29): 221–224. PMID 11809639.
|
AIDS Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV Infection: WHO disease staging system On the Web |
|
American Roentgen Ray Society Images of HIV Infection: WHO disease staging system |
|
Risk calculators and risk factors for HIV Infection: WHO disease staging system |